The B-Cure Laser
Keep ’em Healthy, Keep ’em Happy!
Keeping your pets healthy and happy just got easier.
Laser therapy device for the treatment of orthopedic conditions, dental problems and wounds.
Presenting the state of the art in soft laser therapy, for better health and quality of life for your pets:
Clinical soft laser power – in a light, portable, rechargeable and user friendly medical device, for the rapid, non-invasive and efficient treatment of orthopedic problems, pain, wounds and inflammation. The world’s first portable soft laser device with healing power equal to that of full-sized, stationary, expensive soft-laser machines used only in veterinary hospitals and superior care facilities.
- Accelerates healing and treats pain
- Natural and non-invasive healing
- Easy and safe for home use
- Light, portable and rechargeable
- High energy level
- High efficacy
- Faster return to a happy animal
The B-Cure Laser Device
Contact Fiona for further info and/or a demo
How Does It Work ?
Low Level Laser Energy
When the laser light is absorbed by the body, a number of chain reactions occur including increased blood flow, cellular activity stimulation and enhancement of inter-cellular communication mechanisms as shown in the flowchart below:
Case reports for wound healing, inflammation reduction and minimal scar development
Post-tumor surgery, followed by application of B-CURE® LASER LLLT-808 for quick recovery. Six minutes, twice daily, for 21 days.
B-Cure Laser Vet is a breakthrough development for the treatment of animal orthopedic conditions, pain, injuries and skin disorders, including those shown below (see reference numbers on right):
Clinical Trials Prove High Efficacy of Soft Laser Therapy
During the last decade, over 2,000 studies have been published on the use of soft laser (LLLT) for the treatment of pain relief, and there have been about 100 double-blind studies that prove the clinical value of laser therapy.
It is important to note that most studies conducted up to this point have used the “old generation” devices, with the treatment frequency for patients set at only 1-3 times a week. This is less than the desired frequency that would enable optimal results.
Thanks to its portability and heavy-duty power, the Good Energies™ LLLT-808 enables immediate and more frequent daily treatments, dramatically improving healing.
Neck pain and low-level laser: does it work and how?
Neck pain is a very common symptom. Sometimes it can be brief and inconsequential, but for many people the pain can be severe and disabling.
Published in The Lancet, Roberta Chow and colleagues report a systematic review of randomised trials and conclude that laser radiation provides symptomatic relief of neck pain.
Basic research on the interaction between low-level laser and living tissues dates back more than 30 years, but has been published mainly in non-clinical journals. Chow and colleagues located 16 randomised trials that reported on 820 patients in total. They calculated an average pain reduction on a 100-mm visual analogue scale of about 20 mm immediately after laser therapy, and in at least one trial up to 22 weeks after treatment.
An intervention able to decrease, on average, the level of pain by 20 mm is widely judged to be clinically important, particularly if the effect persists for weeks after treatment. 10 mm is usually regarded as the limit for clinically significant reduction in pain level in pain related trials.
Laser therapy is a modality that can be viewed with scepticism by health-care providers, in part because seemingly unwarranted claims are sometimes made in the lay press and in advertising. The mechanism of action of this technique also remains undefined, but many drugs that are prescribed every day have unclear mechanisms of action. Chow and colleagues suggest that low-level laser treatment might work by anti-inflammatory effects on soft tissues; inflammation has not been noted in most patients with typical nonspecific neck pain. In fact, the pathogenesis of so-called non-specific neck pain is poorly understood. The observation that low-level laser—applied to tender areas or acupuncture-like points—relieves neck pain should prompt new studies about the mechanisms of nonspecific neck pain.
Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials
Roberta T Chow, Mark I Johnson, Rodrigo A B Lopes-Martins, Jan M Bjordal
Background : Neck pain is a common and costly condition for which pharmacological management has limited evidence of efficacy and side-effects. Low-level laser therapy (LLLT) is a relatively uncommon, non-invasive treatment for neck pain, in which non-thermal laser irradiation is applied to sites of pain. We did a systematic review and metaanalysis of randomised controlled trials to assess the efficacy of LLLT in neck pain.
Methods : We searched computerised databases comparing efficacy of LLLT using any wavelength with placebo or with active control in acute or chronic neck pain. Effect size for the primary outcome, pain intensity, was defined as a pooled estimate of mean difference in change in mm on 100 mm visual analogue scale.
Findings : We identified 16 randomised controlled trials including a total of 820 patients. In acute neck pain, results of two trials showed a relative risk (RR) of 1·69 (95% CI 1·22–2·33) for pain improvement of LLLT versus placebo. Five trials of chronic neck pain reporting categorical data showed an RR for pain improvement of 4·05 (2·74–5·98) of LLLT. Patients in 11 trials reporting changes in visual analogue scale had pain intensity reduced by 19·86 mm (10·04–29·68). Seven trials provided follow-up data for 1–22 weeks after completion of treatment, with short-term pain relief persisting in the medium term with a reduction of 22·07 mm (17·42–26·72). Side-effects from LLLT were mild and not different from those of placebo.
Interpretation : We show that LLLT reduces pain immediately after treatment in acute neck pain and up to 22 weeks after completion of treatment in patients with chronic neck pain.
Funding : None.
Published Online November 13, 2009
Nerve Research Foundation, Brain and Mind Research Institute, University of Sydney,
Sydney, NSW, Australia (R T Chow MBBS);
Faculty of Health, Leeds Metropolitan University, Leeds, UK (Prof M I Johnson PhD);
Institute of Biomedical Sciences, Pharmacology Department, University of São Paulo, São Paulo, Brazil (Prof R A B Lopes-Martins PhD);
Faculty of Health and Social Science, Institute of Physiotherapy, Bergen University College, Bergen, Norway (Prof J M Bjordal PT); and
Section of Physiotherapy Science, Institute of Public Health and Primary Health Care, University of Bergen, Bergen, Norway (Prof J M Bjordal)
Dr Roberta T Chow, Honorary Research Associate, Nerve Research Foundation, Brain and Mind Research Institute, University of Sydney, 100 Mallett Street, Sydney, NSW 2050, Australia